Table 3.
Factors predictive of mortality and graft failure at multivariate analysis in human immunodeficiency virus/hepatitis C virus recipients of liver transplantation
| Mortality | HR (95%CI), P value | Graft loss | HR (95%CI), P value |
| HIV infection[14,35] | 2.3 (1.3–3.8), 0.0002 | BMI < 21[35] | 3.2 (1.3–7.7), 0.01 |
| HCV genotype 1[14] | 2.14 (1.24–3.41), 0.006 | Donor age by decade[35] | 1.3 (1.0–1.6), 0.04 |
| Donor index risk[35] | 3.03 (1.57–5.83), 0.001 | HCV-positive donor[35] | 2.5 (1.1–5.6), 0.03 |
| Combined kidney-lT[35] | 3.8 (1.6–9.1), 0.003 | ||
| MELD score[14] | 1.06 (1.01–1.11), 0.023 | ||
| Centers performing < 1 LT/yr[14] | 2.82 (1.30–6.94), 0.009 | ||
| Treated acute rejection1[35] | 2.0 (1.0–4.0), 0.06 | ||
| HIV infection[35] | 1.9 (1.2–3.1), 0.01 |
1In HIV-positive individuals with or without HCV. HCV: Hepatitis C virus; BMI: Body mass index; LT: Liver transplantation; HIV: Human immunodeficiency virus.